chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child was sent home from daycare with a fever, cough, and runny nose. Fever persisted for 5 days with vomiting on day 4. Cough and runny nose continue currently (day 8) with fussiness not typical for child's temperament. Treatment included administering Tylenol and Motrin and trying to help child be physically comfortable. Caregivers had similar symptoms and tested negative for COVID on 2 separate occasions. Doctor visit was attended due to duration of fever and with the onset of vomiting to determine if any other treatment measures were needed/recommended. Child has returned to daycare.
Pt called and had a fever that went up to 104. Pt was seen in the clinic the next day.11/08/2019. Pt was still having a fever.
Therapy non-responder. A pharmacist reported the occurrence of a four year old female subject who did not respond to a series of hepatitis A vaccine inactivated (Havrix) for prophylaxis. The subject was the recipient of a liver transplant, date unspecified. No other relevant medical history was provided. Allergies were not specified. Concurrent medications include "multiple products" including unspecified immunosuppresive agents. On unspecified dates, the subject was administered four injections of Havrix. At an unspecified time post-vaccination, the subject did not seroconvert.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 14-DEC-2012 at 07:45, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 13.25 hours. On 18-DEC-2012 at 18:30, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 12.75 hours. On 22-DEC-2012 at 18:30, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 5 hours. On 17-JAN-2013 at 07:45, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 14.25 hours. On 30-JAN-2013 at 18:00, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 10.5 hours. On 06-FEB-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number H016765). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
Nearly lymph swelling; not at site of injection. Fever and swelling, fatigue. Ibuprofen
burning pain on her left breast, side, arm pit, back and arm/ a little bit of the pain comes and goes; swelling; This is a spontaneous report from a contactable consumer. A 92-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 26Jan2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included lung cancer and breast cancer surgery on the left side many years ago and she also has a tumor from an unknown date and unknown if ongoing. The concomitant medications includes a lot pain medication for other reasons from an unknown date and unknown if ongoing. On an unspecified date of 2021 caller states her injection was given in her right arm. Caller states she has a burning pain on her left breast, side, arm pit, back and arm. Caller states there is a little bit of swelling and the pain comes and goes. Caller states she also takes a lot pain medication for other reasons. Caller would like to know if her symptoms are normal for people who have had cancer and lymph nodes removed. Caller may also be postponing second dose of vaccine. The outcome of the events was unknown.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
The shot triggered my Wartenberg's; it was the worst Wartenberg's attack to date.  I had more intense than normal nerve tingling and burning in my face and lower legs.  The pain in my head from the nerves was the worst I have ever experienced.  It lasted two full days before it began to slowly subside.
Late night after vaccine the right arm became tender. The next afternoon a fever of 101.7 started along with a large inflamed circle at the site of shot.
After receiving the 2nd dose, I experienced a fever and chills. On January 28th 2021, I developed Bell's Palsy on the right side of my face.
Dizziness & HYPERtension Narrative: Patient reports light headedness, dizziness, "heavy" feeling to monitoring staff. Patient given some water and monitored for 30 minutes by monitoring staff. BP 139/111 HR 75, recheck BP 141/99 HR 80 reported to this RN. Event reported to this RN at 1350, patient returned to workstation.
Case number PHHY2011US39090 is an initial report from a nurse received on 09 May 2011: This report refers to a 19-year-old female patient. The patient was vaccinated with MENVEO (batch number X10028) on 09 May 2011. The patient received only the MenCYW-135 liquid vaccine component of MENVEO on 09 May 2011. The patient did not present any adverse reaction to vaccine.
Few days after shot noticed rise in blood pressure and it has been elevated since that time (not dangerously so).  On Nov. 28 woke up with bad headache, sore throat, and severe pain in left ear.  Next day went to Urgent Care and was diagnosed with ear infection and put on one week of antibiotic.  Headaches have continued to this date and throat sore but less painful.  Pain in ear gone.  Also, since booster shot, have experienced fatigue on and off consistently.
Information has been received from a registered nurse regarding a patient of unkonwn age and gender. On 25-NOV-2013, the patient was administered with a dose of VARIVAX (Merck) (Lot # 0079AE, expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
blister w/red ring began on ankle-redness & swelling inc;many more spots appeared;tx w/Zyrtec & claritin w/no help;spots itch & gets extremely tired & sleeps;volleyball size & appear as bruise;MD states something lit up immune system;
arm is swelled up; cannot even stretch my arm out because of the nerve and is real red; cannot even stretch my arm out because of the nerve and is real red; whole arm is aching;  cant even lift nothing with this arm; cannot even stretch my arm out because of the nerve and is real red got a big all hot; whole arm is aching;  cant even lift nothing with this arm; cannot even stretch my arm out because of the nerve and is real red; This is a spontaneous report from a contactable consumer (patient). A 52-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: ER8730), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. Medical history included diabetes, rheumatoid arthritis, hypertension. The patient had unspecified concomitant medication. On an unknown date, the patient's arm was swelled up, the patient couldn't even stretch his/her arm out because of the nerve and was real red which got a big and all hot, whole arm was aching; couldn't even lift nothing with that arm, As the therapeutic measures the patient put hot towel on it and was rubbing ethyl (not clear) for the reported events except vaccination site movement impairment. The outcome was unknown for the reported events.  No follow-up attempts are possible. No further information is expected.
Large area on arm swelled, hot, bright red and painful.  Area approximately 5"x6".  Headache.  Duration approximately 2 weeks.
Began 1/17/04 with bumps on torso and extremities; pruritic.
day p/vax pt had a shaking episode but never lost consciousness became incontinent of urine;not self x 48hrs
patient had acute stroke 4/10/2021 requiring hospitalization. suspected related to paroxsymal afib etiology. Family requesting this be reported to VAERS as possible vaccine reaction.
Patient experienced local redness and swelling at injection site that continued to spread down arm. Two days post-vaccination she noticed pain and tingling up to her shoulder and down to her hand. Went to PCP and was given Rx for KEFLEX 500 one tid x 10d. Pt also experienced chills but no fever.
At approx 24h after injection i noticed small, tender,  swollen lump along mandible. Lump not in location of lymph node. By end of evening had localized swelling to bilateral cheekbones, bilateral mandible joints, and above right side of upper lip. All points were swollen and tender to touch. These are locations where i had dermal filler injected approx 5 months prior to vaccine. I self medicated with Benadryl 25mg every day x3 days and 20mg prednisone every day x2 days with resolution of swelling and tenderness. No residual symptoms after 3-4 days from onset
30 hrs p/vax lt deltoid red welt appeared 4" wide (as big as moms hand) hot to touch & sore (according to pt);
I believe that the vaccines caused my joint and some muscle pain to increase. I do have some joint pain but I noticed after the shots that it increased substantially and didn't let up. I used to walk daily now when I do walk it is painful
During a routine follow up call to staff, reported swelling on both her eyes and lips as well as severe pain on her jawline and headache. Staff advised to seek medical help. Unknown if staff went to urgent care/er.  As of 7pm, staff txted she is recovering but did not confirm/deny if medical assistance was sought.
Rash onset within hours of vaccination on 7/21/22 with itchy red bumps, progressed over 2 days to widespread cutaneous erythema multiforme (approx 30% BSA), fever, malaise. No mucosal involvement, no sloughing when examined on 7/23/22. D/w pediatric infectious disease specialist, decided to closely monitor outpatient, start oral steroids.  Note: maternal hx SJS, suspect genetic predisposition, but no HLA subtyping done to date
isn't going to receive the second dose in the series due to the dizziness; dizziness happens a lot a night while trying to sleep/dizziness is off and on/if she bends forward, she feels dizzy/dizziness happens a lot a night while trying to sleep; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (isn't going to receive the second dose in the series due to the dizziness) and DIZZINESS (dizziness happens a lot a night while trying to sleep/dizziness is off and on/if she bends forward, she feels dizzy/dizziness happens a lot a night while trying to sleep) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism, Hypertension and Stomach discomfort. Concomitant products included LEVOTHYROXINE, LOSARTAN, AMLODIPINE, METOPROLOL, OMEPRAZOLE, PRAVASTATIN, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (isn't going to receive the second dose in the series due to the dizziness) and DIZZINESS (dizziness happens a lot a night while trying to sleep/dizziness is off and on/if she bends forward, she feels dizzy/dizziness happens a lot a night while trying to sleep). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (isn't going to receive the second dose in the series due to the dizziness) and DIZZINESS (dizziness happens a lot a night while trying to sleep/dizziness is off and on/if she bends forward, she feels dizzy/dizziness happens a lot a night while trying to sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: No new information was provided
2 areas of inflammation at vaccine sites upper left leg #1 Halo only.  #2 quarter size red flat non tender area extending from 2nd site.
Presented to ER w/cold-like symptoms; cxr suggestive of COVID pna; COVID test returned positive. Pt remained on RA and did not require any specific treatment
L thigh cellulitis as DX'd by ER 3/28/07 S/P imms
Typical bells palsy flare for individual with severe headache , right side facial droop, right eye also crosses.
Information has been received from a registered nurse concerning a 19 year old female who on 12-MAY-2008 was vaccinated intramuscularly in the left arm with a first dose of GARDASIL (lot # 660387/1967U) 0.5 mL and on 19-DEC-2008 was vaccinated with a second dose of GARDASIL (lot # 660585/0297X). On 20-DEC-2008 the patient experienced swelling of her entire left arm and hand. On unspecified date, the patient recovered. This AE was mentioned to the physician by the patient's mother during an office visit with sibling of the patient. Additional information has been requested. Follow up information was received from the registered nurse. It was reported the patient with no illness at time of vaccination, no adverse event follow prior vaccination and no pre-existing allergies on 19-OCT-2008 was vaccinated intramuscularly with a second dose of GARDASIL in the left deltoid. On 19-DEC-2009 (previously reported as 20-DEC-2008) the patient experienced swelling of her entire left arm and hand. On 23-DEC-2008 the patient recovered. No further information available.
she experienced arm sore and upset stomach after the 1st dose; she experienced arm sore and upset stomach after the 1st dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), ABDOMINAL DISCOMFORT (non-serious), outcome "unknown" and all described as "she experienced arm sore and upset stomach after the 1st dose".  Additional information-The patient received her 2nd dose of the vaccine on (25May2021) morning. Wants to know if she can take Advil in case she experiences headache, nausea. She experienced arm sore and upset stomach after the 1st dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received vaccines in office. After patient complained of headache and dizziness. Cold compress and BP taken. 45 min post administration patient left office. Follow up 24 hrs later showed patient still with headache and dizziness.
This initial spontaneous report was received from a patient's relative concerning a 68 year-old female patient. There was no pertinent medical history or drug allergies/drug reactions described. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX subcutaneous injection (dose, lot# and expiration date were not provided). There was no concomitant medication reported. On an unknown date reported as "while on vacation", the patient developed a "lesions" on her forehead and over her right eye; she went to see an unknown ophthalmologist, who stated "it was a rash", then saw her own ophthalmologist, who stated, "it appeared as though she had shingles". The ophthalmologist then treated her with unspecified medications. Product quality complaint (PQC) was not involved. At the time of the report, the outcome of the events was not recovered. The relatedness between the events to the suspect drug was not reported. Additional information is not expected as no reporter details were provided.
This is a spontaneous case, initially received from a pharmacist on 29-Oct-2018, concerning a 77-year-old elderly male patient. The patient's concomitant medications were unknown. On an unspecified date in Oct-2018 (reported as 3 weeks ago), the patient was administered expired FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252668 and expiry date: 29-Jun-2018]. On an unspecified date in Oct-2018 (within a couple of days as reported), after vaccination, the patient felt pain when he lifted his arm and was treated for possible shingles. At the time of this report, the outcome of the events was not reported. The reporter assessed the case as non-serious.
I am not feeling well; I am having the fever; there is a mess with my breathing; I am keep sweating up under the fan. I keep sweating. I am breaking in sweat.; This is a spontaneous report from a contactable consumer. A 54-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number: FA6780, Expiry date: unknown, at the age of 54-year-old), dose 1 via an unspecified route of administration on 29Jun2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, she was having some side effects. She was not feeling well. There is a mess with her breathing, little bit. She was having fever and kept sweating up under the fan. She was breaking in sweat all on 30Jun2021. Outcome of the events was unknown.
Narrative:  93yo pt residing at nursing facility died on 5/28/21 at community hospital. Pt with hx of htn, hdl, dm, arthralgis, bph, arthritis in hip/leg, seasonal allergies. Pt had received covid vaccines on 2/6/21 & 4/19/21. Pt's death appears unrelated to vaccinations.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of covid-19.  Clinical course: COVID 19 Treatment included Paxlovid (Treatment start date: 04May2022 Treatment stop date: 06May2022)   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Dizziness, Headache, Tachypnea, HR 130, Throat was closing,  Narrative:
Patient stated she developed a baseball-sized welt on left arm and very swollen after receiving vaccines 9/6/19. Arm is very hard and sore. Patient did not report anaphylactic symptoms. Advised patient to seek medical care immediately.
pt exp redness & itching w/in 12hr of vax;pt seen 72hr later & noted to have 1 1/2cm diameter of erythema, min edema w/tenderness advised to use ice & antihistamine;
This spontaneous report was received from a licensed practical nurse and refers to a 9 weeks infant (gender not reported). There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On 21-SEP-2016, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # L046319, expiration date: 28-SEP-2017, dose was not reported), orally. No symptoms were reported. Administered doses of vaccines experienced the temperature excursion of 32 degrees Fahrenheit for 15 minutes and 31 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1608USA012908: US-009507513-1608USA012916: US-009507513-1705USA004961: US-009507513-1705USA004964: US-009507513-1705USA004973: US-009507513-1705USA004952: US-009507513-1608USA012794: US-009507513-1705USA004967: US-009507513-1705USA004963: US-009507513-1705USA004960: US-009507513-1705USA004965: US-009507513-1705USA004962:
In the first 15 minutes I started to experience a strong metallic taste in my mouth that lasted about 3 days before going away.  Nausea, slight headache and fatigue.
I had a reaction from the shot. I had chest pain and I could not breath that lasted for about 24 hours. I had fever and a headache that lasted for about 3 days. Then on Jan 15th, I tested positive for COVID-19. I had a fever, body aches, sore throat, difficulty breathing, and coughing that lasted for about 3 weeks. I have long hall COVID-19 test. I am having difficulty breathing, chest pain and coughing. I went the doctor about this. They did x-ray and medicine. The x-rays show that my lungs are scars and my lungs a full of fluids.
Persistent dry cough, fever, nasal congestion, chills, and diarrhea beginning evening of vaccine dose.  Wife with similar symptoms. Proceeded to outside facility ER, unclear if COVID test positive.
Noticed a rash starting behind his left ear. From there it spread to his posterior, groin, back, chest, and face. Most noticeable on posterior, penis and stomach. Rash itches and burns when cleaned with soap. Rash continues to today. Saw doctor 7/31 about rash. Prescribed prednisone.
01/07/2021 - Woke up at 10AM with pulsing pains in left side of chest.  I took asprin and it went away. 01/08/2021- Woke up at 11AM with slight pulsing pains again in left side of chest.  no medicine taken.  It came and went as the day went on - felt similar to heartburn. Thought I should report cause I've never woken up with these pains prior to this.
This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Felt did not get up and go to do anything, after COVID-19 vaccination) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) for Chronic lymphoid leukemia.    Concurrent medical conditions included Chronic lymphoid leukemia.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and IBRUTINIB (IMBRUVICA) (Oral) at an unspecified dose. On an unknown date, the patient experienced GAIT DISTURBANCE (Felt did not get up and go to do anything, after COVID-19 vaccination). At the time of the report, GAIT DISTURBANCE (Felt did not get up and go to do anything, after COVID-19 vaccination) outcome was unknown.            No concomitant product reported by the reporter.  The reporter's causality for the event of felt did not get up and go to do anything, after COVID-19 vaccination with drug Ibrutinib was not provided. It was unknown if patient was enrolled in COVID-19-Vaccine trial.  No treatment medication reported by the reporter.